Overview Principal Investigator Targeting (PIT) is a clinical development SaaS platform by Chryselys that empowers pharmaceutical and biotech sponsors to strategically identify, select, and collaborate with the most effective principal investigators (PIs) for clinical trials. PIT uses data-driven analytics to match trial requirements with investigators’ expertise, patient recruitment networks, and historical performance, enabling accelerated enrollment, reduced costs, enhanced data quality, and optimized study outcomes. By avoiding conflicts of interest and emphasizing proven investigator success, PIT strengthens clinical trial execution and speeds time-to-market for therapies.

Features and Capabilities:

• Expertise Matching: PIT evaluates investigator experience against specific therapeutic needs, ensuring alignment of scientific knowledge and trial goals.
• Competitive Edge: The platform helps avoid investigators engaged in competing trials, protecting research integrity and improving collaboration.
• Recruitment Acceleration: Identifies PIs with broad patient networks, increasing the speed and quality of patient enrollment.
• Performance Reliability: Focuses on investigators with a strong track record of study success, timely data submission, and adherence to protocols.
• Data Quality Assurance: Ensures clinical data integrity through investigator diligence in assessments, reporting, and compliance.
• Relationship Cultivation: Facilitates long-term partnerships with key investigators, enhancing future research collaboration.
• Strategic Integration: PIT fits within broader clinical development strategies to improve operational planning and execution of trials.